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Background: In humans there is a positive association between epicardial adipose tissue (EAT) volume and
coronary atherosclerosis (CAD) burden. We tested the hypothesis that EAT contributes locally to CAD in a pig
model.
Methods: Ossabaw miniature swine (n = 9) were fed an atherogenic diet for 6 months to produce CAD. A 15 mm
length by 3–5 mm width coronary EAT (cEAT) resection was performed over the middle segment of the left
anterior descending artery (LAD) 15 mm distal to the left main bifurcation. Pigs recovered for 3 months on
atherogenic diet. Intravascular ultrasound (IVUS) was performed in the LAD to quantify atheroma immediately after
adipectomy and was repeated after recovery before sacrifice. Coronary wall biopsies were stained
immunohistochemically for atherosclerosis markers and cytokines and cEAT was assayed for atherosclerosis-related
genes by RT-PCR. Total EAT volume was measured by non-contrast CT before each IVUS.
Results: Circumferential plaque length increased (p < 0.05) in the proximal and distal LAD segments from baseline
until sacrifice whereas plaque length in the middle LAD segment underneath the adipectomy site did not increase.
T-cadherin, scavenger receptor A and adiponectin were reduced in the intramural middle LAD. Relative to control
pigs without CAD, 11β-hydroxysteroid dehydrogenase (11βHSD-1), CCL19, CCL21, prostaglandin D2 synthase,
gp91phox [NADPH oxidase], VEGF, VEGFGR1, and angiotensinogen mRNAs were up-regulated in cEAT. EAT volume
increased over 3 months.
Conclusion: In pigs used as their own controls, resection of cEAT decreased the progression of CAD, suggesting
that cEAT may exacerbate coronary atherosclerosis.
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In most recent reviews of human cross-sectional studies
[1-3], the amount of epicardial adipose tissue (EAT),
measured either as thickness by echocardiography over
the right ventricle or as total volume by computed tom-
ography (CT) scans, correlated directly with coronary
artery disease (CAD) burden. Additionally, in prospec-
tive case-cohort [4] and in case–control [5] studies,
EAT volume predicted future CAD events and myocar-
dial ischemia. However, one report did not show that* Correspondence: msturek@iu.edu
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reproduction in any medium, provided the orEAT volume added incremental predictive value over
established CAD risk factors [6].
After regression analysis, EAT volume expansion in
CAD occurs independently of associated increases in
visceral abdominal and total body fat mass as well as
changes in other CAD risk factors [2,3]. This epidemio-
logical evidence together with pathophysiological data
showing increased chronic inflammatory cell infiltrates [7]
and up-regulation of pro-inflammatory, redox, macrophage
marker, and angiogenic gene expression specifically in
EAT sampled from humans undergoing coronary ar-
tery bypass for severe CAD [8] is the basis for the
hypothesis that EAT might contribute locally and det-
rimentally to coronary atherogenesis. However, to ourtral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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that EAT plays a role in coronary atherogenesis.
Our laboratory has characterized Ossabaw miniature
swine as a model of CAD. The “thrifty genotype” of
Ossabaw swine has enabled survival in the feast and
famine ecology, i.e. extreme variations in food availabi-
lity, of Ossabaw Island [9]. In the sedentary environment
of captivity, our group induced CAD in this breed of
pigs by feeding them a hypercaloric, atherogenic diet
[9-12]. This animal’s coronary arterial supply more
closely resembles that of humans compared to rodent
research models. Additionally, rodent EAT is unpredic-
table in amount and not easily discerned, whereas the
pig’s EAT is clearly demarcated macroscopically [9,11],
can be imaged radiologically [9], and potentially might
be amenable to surgical removal [13]. We tested the
hypothesis that surgical excision of EAT in direct contact
with the coronary artery (cEAT) of pigs would attenuate
underlying plaque progression in vivo.
Methods
Animal model and protocol
We produced CAD in 9 castrated male Ossabaw mini-
ature swine by feeding them 1000 g, once a day,
of a high fat/cholesterol/fructose, atherogenic diet for
6 months starting at 6 months of age. The diet provided
16.3% kcal from protein, 40.8% kcal from complex car-
bohydrates, 19% kcal from fructose, and 42.9% kcal from
fat. Fat calories derived from a mixture of lard, hydroge-
nated soybean oil, and hydrogenated coconut oil. It was
supplemented with 2.0% cholesterol and 0.7% sodium
cholate by weight (KT324, Purina Test Diet, Richmond,
IN). Age- and gender-matched lean control swine were
fed 750 g of regular chow (5 L80, Purina Test Diet,
Richmond, IN) containing 18% kcal from protein,
71% kcal from complex carbohydrates, and 11% kcal
from fat once a day. All animals had free access to drink-
ing water. After 6 months on the diet, CT was per-
formed to quantify EAT surrounding the heart. Surgical
excision of cEAT covering the middle segment of the left
anterior descending (LAD) artery, which we termed se-
lective coronary adipectomy, was then conducted via a
thoracotomy, as described below, followed immediately
by intravascular ultrasound (IVUS) quantification of
CAD. Following the procedure, the same baseline diet
was continued during a 3-month recovery period at the
end of which identical CT followed by IVUS were per-
formed prior to sacrifice and tissue collection. Control
pigs did not undergo IVUS or adipectomy because they
have been shown previously to develop minimal or no
CAD over the time course of this experiment [12]. In
both adipectomy and control pigs at sacrifice, cEAT for
mRNA analysis was resected from the adventitial
surface of the LAD just proximal to the middle LADadipectomy site, and as a comparator, paracardial fat was
sampled from the mediastinal surface of the pericardium
towards the apex of the heart. Samples were stored
at −80°C. Biopsies of proximal, middle and distal LAD
were taken and preserved for immunohistochemistry. All
protocols involving animals were approved by an Institu-
tional Animal Care and Use Committee and complied
fully with recommendations in the Guide for the Care and
Use of Laboratory Animals [14] and the American Vete-
rinary Medical Association Panel on Euthanasia [15].
Intravascular ultrasound
Following an overnight fast, swine received a 2.2 mg/kg
of xylazine (Webster Veterinary, Devens, MA) and
5.5 mg/kg of telazol (Fort Dodge Animal Health, Fort
Dodge, IA) intramuscular injection to induce anesthesia.
Swine were intubated and anesthesia was maintained
with 2-4% isoflurane in 100% O2 as a carrier gas. The
isoflurane level was adjusted to maintain anesthesia with
stable hemodynamics. Heart rate, aortic blood pressure,
respiratory rate, and electrocardiographic data were con-
tinuously monitored throughout the procedure. A 7 F
introducer sheath was inserted into the right femoral ar-
tery and heparin (200 U/kg) was administered under
sterile conditions. A 7 F guiding catheter (Amplatz L,
sizes 0.75-2.0; Cordis, Bridgewater, NJ) was advanced to
engage the left main coronary ostium. A 3.2 F, 30 MHz
IVUS catheter (Boston Scientific, Natick, MA) was ad-
vanced over a 0.014 inch diameter percutaneous translu-
minal coronary angioplasty guide wire (Boston Scientific,
Natick, MA) and positioned in the LAD. Automated
IVUS pullbacks were performed at 0.5 mm/sec in the
LAD. Throughout the procedure angiography was per-
formed to place the guiding and IVUS catheters in their
desired positions. The IVUS catheter, guide catheter, and
introducer sheath were removed and the right femoral
artery ligated. The incision was closed and the animal
was allowed to recover. Cefazolin (1000 mg; WG Critical
Care, Lake Forest, IL) was given twice a day for six days
following the procedure.
All IVUS pullback images were analyzed off-line (Win-
dows Media Player, Microsoft) at 1 mm intervals. The
LAD was divided into 3 segments: proximal (0–15 mm),
middle (15–30 mm) and distal (30–45 mm) with 0 mm
starting at the bifurcation of the left main into LAD and
circumflex. Three IVUS pullback images were captured
per vessel segment. Using the Image-Pro Plus software
(Media Cybernetics, Rockville, MD), lumen area (LA)
was found by tracing the vessel lumen. From LA, lumen
circumference (LC) was calculated for each vessel seg-
ment by the following formula: LC = 2π [√ (LA/π)].
To derive wall coverage (WC) by plaque, the circumfe-
rence of each cross-sectional image was divided into 16
equal segments. Percent wall coverage was calculated as
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product of average WC × LC, a circumferential plaque
length for each vessel segment was found. As an ex-
ample, the following results are presented from a pro-
ximal coronary artery segment:
LA 21.40 mm2; LC 16.40 mm; WC 29.58%; circumfe-
rential plaque length = 4.85 mm. Pullbacks were used for
7 out of 9 animals due to restrictions from vasospasms
or lumen diameter. Using a 2-way analysis of variance
(ANOVA), average circumferential plaque length per
vessel segment was compared pre- and post-adipectomy.
Selective adipectomy
Under general anesthesia, cardiovascular monitoring
(both as described above), and using aseptic surgical
techniques, all adipectomies were performed on the
LAD with access via left thoracotomy by the cardiac
surgeon. Figure 1A shows the anatomical structures
and distribution of EAT over the epicardium of a repre-
sentative pig heart ex vivo. A Thoratrak Retractor
(Medtronic; Minneapolis, MN) was utilized for minimal
rib spreading and as a base for the Octopus cardiacFigure 1 Ossabaw swine heart anatomy and adipectomy procedure. A
tissue; b. left anterior descending artery; c. circumflex artery; d. left ventricle
stabilizing the myocardium and left anterior descending (LAD) segment. C.
coronary artery; LAD, left anterior descending artery; CFX; circumflex artery.stabilizer (Medtronic; Minneapolis, MN) (Figure 1B).
The pericardium was opened and cradled to the drapes
exposing the LAD. The Octopus was then positioned to
stabilize the middle LAD segment. Using the bifurcation
of the left main into LAD and circumflex as the refer-
ence point, cEAT was excised sharply starting 15 mm
distal to this landmark for a distance of 15 mm along
the length of the LAD and 3–5 mm on both the right
and left lateral aspects of this part of the vessel
(Figure 1C). Non-absorbable Prolene sutures were
placed to control epicardial venous bleeding from
resected fat typically to the left side of the LAD. The lig-
atures demarcated this site for later tissue collection at
sacrifice. When possible, the pericardium was loosely ap-
proximated with interrupted sutures. The chest was then
closed in layers in the standard fashion. Pleural air was
evacuated by means of suction on an intrapleural red
rubber catheter being withdrawn during a valsalva
breath and closure of the chest wall musculature. One of
the 9 animals succumbed intra-operatively from an
acute myocardial infarction complicated by refractory
ventricular fibrillation documented by ECG and by. Ossabaw heart (left anterior view) ex vivo. a. epicardial adipose
; e. pulmonary artery; f. aorta. B. Adipectomy procedure with Octopus
Surgical landmarks for excision of epicardial adipose tissue; RC, right
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There were no noticed post-operative complications in
the remaining swine.
Immunohistochemistry
Sections of the LAD were prepared using techniques
previously described by us [16]. Samples of LAD were
dissected and immersed in neutral-buffered 10% forma-
lin for a minimum of 24 h and then processed to
paraffin embedment. The proximal, middle, and distal
samples of LAD were obtained consistently from the
same location in all pigs. Five-micrometer sections were
cut with an automated microtome (Microm, Thermo
Fischer Scientific, Bellefonte, PA), floated onto positively
charged slides (Thermo Fischer Scientific), and deparaf-
finized. The slides were then steamed in citrate buffer at
pH 6.0 (Dako target retrieval solution S1699; Dako,
Carpenteria, CA) for 30 min to achieve antigen retrieval
and subsequently cooled for 30 min. Next, the slides
were stained manually with sequential Tris buffer or
water wash steps performed after each protocol step.
Sections were incubated with avidin biotin two step
blocking solution (Vector SP-2001; Vector Laboratories,
Burlingame, CA) to inhibit background staining and in
3% hydrogen peroxide to inhibit endogenous peroxidase.
Nonserum protein block (Dako X909; Dako) was applied
to inhibit nonspecific protein binding. Immunostaining
was performed using scavenger receptor A (SRA-ES;
1:100 dilution, Transgenic Inc. #KT-022), tryptase (1:600
dilution, Dako #M7052), CD-3 (1:600 dilution, Dako
#A0452), monocyte chemoattractant protein-1 (MCP-1;
1:100 dilution, PeproTech #500-P76), resistin (1:800 di-
lution, Phoenix Pharmaceuticals #H-02840), T-cadherin
(1:1000 dilution, Abgent #CDH13, AP14346), adiponec-
tin (1:200, Chemicon #MAB 3604) or tumor necrosis
factor-alpha (TNF-alpha; 1:100 dilution, R&D #AF690).
All the primary antibodies were diluted using antibody
diluent (S0809; Dako) and were incubated with the tis-
sue sections overnight at 4-C. After the appropriate
washing was completed, sections were incubated with
biotinylated antimouse or rabbit link secondary antibody
and then peroxidase-labeled streptavidin (LSAB + kit,
peroxidase, K0690; Dako). Diaminobenzidine (K3468;
Dako) was applied for 5 min and allowed visualization of
primary antibody staining. Sections were counterstained
with Mayer hematoxylin for 1 min, dehydrated, and co-
verslipped. For negative controls, histological sections
were prepared as described, but incubation in primary
antibody was replaced with Tris buffer.
Immunostaining analysis was performed in the entire
vessel wall (i.e. intima to external elastic lamina boun-
daries) in order to quantify the presence of SRA, tryp-
tase, CD3, MCP-1, resistin, T-cadherin, adiponectin or
TNF-alpha. Sections were examined using an OlympusBX61 photomicroscope (Olympus, Melville, NY), and
pictures were captured at 20x magnification. Image-Pro
Plus (version 6.2.0.424; Media Cybernetics, Inc., Silver
Spring, MD) was used to identify and quantify the posi-
tive area of staining. Percent staining of the vessel wall
was calculated from the data for positive staining and
total area. An experienced investigator that was blinded
to treatment group’s identities performed the selection
of target areas, photography, and image analysis.
mRNA analysis
mRNA Isolation
Approximately 0.2 to 0.5 g of frozen cEAT and paracar-
dial fat from adipectomy and control animals was
homogenized with 5 ml of a monophasic solution of
phenol and guanidine isothiocyanate (TRIzol reagent,
Invitrogen, Carlsbad, CA).
RT-PCR
The mRNA assay involved real-time quantitative PCR.
Transcriptor First Strand cDNA synthesis Kit from
Roche Diagnostics was used on equal quantities of RNA
to prepare the complementary DNA (cDNA). The Roche
Lightcycler 480 Real-time RT-PCR system and Roche’s
Universal Probe Library of short hydrolysis Locked
Nucleic Acid (LNA) dual hybridization probes combined
with the primers recommended by their web-based
assay design center [http://www.universalprobelibrary.
com] were used for mRNA quantification. Integrated
DNA Technologies (Coralville, IA) synthesized the
primers. Twenty five genes related to atherosclerosis
were selected (Table 1). Fifteen mRNAs were targeted
for their roles in inflammation, 4 for their roles in oxida-
tive stress as well as reactive oxygen species regulation
and 6 in control of angiogenesis and endothelial cell
function. In each assay, 55 ng per tube of total RNA
(determined by absorption at 260 nm in a nano spectro-
photometer) was used. The data were obtained as cross-
ing point values (Cp) obtained by the second derivative
maximum procedure as described by Roche Applied
Science technical notes LC10/2000 and 13/2001 [http://
www.roche-applied-science.com/sis/rtpcr/htc/index.jsp].
Relative quantification of the data was calculated using
the absolute Cp values based on analyzing the same
amount of total RNA in each assay as recommended by
Bustin [17].
Computed tomography
CT scans to quantify changes in EAT were analyzed by
one observer. EAT was defined as fat between the inner
surface of the visceral pericardium and epicardial surface
of the myocardium [18,19]. Paracardial fat was defined
as fat lying within the mediastinum superficial to the
parietal pericardium [18,19]. Representative images are
Table 1 Ratio of gene expression in fat from obese and
lean Ossabaw pigs
Ratio of obese/lean
mRNA Epicardial Fat Paracardial Fat
Inflammatory adipokines or proteins associated with inflammation
11β HSD-1 16.0# 1.2
CCL19 14.0# 4.4*
Adiponectin 6.7*** 5.0*












Oxidative stress/reactive oxygen species regulation
gp91phox [NADPH oxidase] 72.0# 5.4***
SOD 2.0 1.5
cytochrome C oxidase 1.5 1.5
cyclooxygenase 2 2.2 1.1






adenosine receptor 1 0.7 0.9
Legend: mRNA ratios of obese (n = 8) to lean (n = 8) swine. Significant values
are depicted as follows: * 0.05, ** 0.025, *** 0.01, # 0.001.
McKenney et al. Journal of Cardiothoracic Surgery 2014, 9:2 Page 5 of 11
http://www.cardiothoracicsurgery.org/content/9/1/2shown in Figures 2A, B and C. The pigs were scanned
using a Philips Brilliance 64 detector scanner (Cleveland,
OH) while sedated using 4% Isoflurane (Webster Veter-
inary, Devens, MA) supplied by mask. Imaging was
performed with retrospective electrocardiogram (ECG)
gating and without the administration of intravenous
contrast from above the aortic arch to below the heart.
Additional scan parameters included a 64 × 0.625 colli-
mation, pitch of 0.2, rotation time of 0.4 seconds, 120
kVp, and 800–1000 mAs. Images were reconstructed
with a slice thickness of 0.67 mm and increment of
0.67 mm using a CB filter. A batch was first created to
ensure equal amounts of data were analyzed and in-
cluded for each image set. The baseline and pre-sacrificeimages were then aligned side-by-side to ensure similar
magnification and orientation. Transverse images were
analyzed by starting at the superior aspect of the atrial
appendage. Sternal, vertebral body and cardinal land-
marks were utilized to insure similar alignment. The
slice thickness of each image produced was 3 mm with-
out overlap, yielding about 40 images per heart in each
batch. Regions of interest (ROI) were drawn by hand
using quantitative computer tomography angiography
(Q-CTA) software on a Philips Extended Brilliance
Workspace (Version 3.5) to include the entire heart.
Vessels leaving and entering the heart were included
until they were noticeably detached from the heart. The
Hounsfield unit (HU) value is similar for blood, muscle,
and soft tissue, thus making the vessels appear as part of
the heart until a visible distance is evident between the
heart and the vessel. In all cases vessels were split in the
ROI through their center as the pericardium encapsu-
lates the most proximal regions of the vessels leaving
and entering the heart. The software highlighted all tis-
sue that matched the HU intensity of a reference ROI
drawn in known subcutaneous fat (at the level of the
carina). The fat area measurements of the images were
then multiplied by their slice thickness to determine fat
volume. Volumes of EAT were compared before adipect-
omy and at the end of the recovery period. Inter-
operator coefficient of variation was 6.2%, while
intra-operator variation was 1.0%.
Statistics
Statistical analysis was performed via Microsoft Excel
2010, utilizing ANOVA, regression analysis and post hoc
1- and 2-tailed paired student t-tests to examine signifi-
cance. All values are given as mean ± SE. A p value
<0.05 was considered statistically significant.
Results
Metabolic characteristics
At adipectomy, pigs on the atherogenic diet had devel-
oped CAD and its risk factors including hypertension,
obesity, increased LDL/HDL ratio, insulin resistance,
glucose intolerance and increased triglyceride levels
compared to age-matched lean controls (Table 2). Other
than the increase in body weight, these characteristics
remained constant during the 3 month recovery follow-
ing adipectomy (data not shown).
IVUS
Representative IVUS images in Figure 3 show a normal
coronary lumen (A) as well as partial (B) and complete
circumferential (C) neointimal plaque formation. The re-
sults of IVUS pullbacks revealing atherosclerosis in each
15 mm length proximal, middle and distal portions of
the LAD from its origin are shown in Figure 3D. Over
Figure 2 Epicardial fat CT imaging. Transverse slices were taken at the level of the carina, approximately midway between the base and apex
of the heart. A. Landmark CT: a. subcutaneous adipose tissue; b. sternum; c. heart; d. lungs; e. bronchi. B. Representative ROIs: a. subcutaneous
reference ROI; b. ROI drawn to encapsulate pericardium (fat inside ROI considered epicardial fat); C. CT image after fat analysis (maroon = fat); a.
ROI arrows drawn to show epicardial fat locations; b. paracardial fat. CT = computed tomography, ROI = region of interest.
Table 2 Metabolic characteristics of Ossabaw swine
Parameter Obese (n = 9) Lean (n = 9) P value
Weight at adipectomy (kg) 77 ± 3 N/A N/A
Weight at sacrifice (kg) 91 ± 1 54 ± 2 < 0.001
Total cholesterol (mg/dL) 576 ± 40 57 ± 6 < 0.001
Fasting triglycerides (mg/dL) 108 ± 21 32 ± 3 < 0.001
LDL (mg/dL) 502 ± 36 33 ± 1 < 0.001
HDL (mg/dL) 53 ± 7 24 ± 2 < 0.005
LDL/HDL ratio 11 ± 2 1 ± 0.1 < 0.001
Fasting glucose (mg/dL) 80 ± 5 73 ± 6 0.334
Plasma glucose peak (mg/dL) 820 ± 35 527 ± 24 < 0.001
Plasma glucose AUC 17138 ± 1004 9274 ± 377 < 0.001
Fasting insulin (μU/ml) 21 ± 6 5 ± 1 0.020
Plasma insulin peak (μU/ml) 172 ± 19 33 ± 4 < 0.001
Plasma insulin AUC 4413 ± 432 667 ± 121 < 0.001
Systolic blood pressure (mmHg) 138 ± 2 110 ± 3 <0.001
Diastolic blood pressure (mmHg) 79 ± 2 67 ± 2 <0.030
Legend: Adipectomised obese swine were age matched to lean swine. Values
for adipectomised swine were obtained just prior surgery (n = 9), except for
body weight at sacrifice (n = 8). AUC = area under curve, HDL = high density
lipoprotein, LDL = low density lipoprotein.
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in the proximal LAD increased from 4.45 ± 0.54 to
8.24 ± 1.03 mm (p < 0.01, Two-way ANOVA and Bonfer-
roni post-hoc) and in the distal LAD from 1.98 ± 0.35
to 5.74 ± 0.75 mm (p < 0.01, Two-way ANOVA and
Bonferroni post-hoc). By contrast, circumferential plaque
length in the middle LAD increased from 5.60 ± 0.90
to 7.64 ± 1.03 mm which was not statistically different
(p > 0.05, Two-way ANOVA and Bonferroni post-hoc).
There was no difference between baseline mean prox-
imal and middle LAD plaque lengths (p = 0.26), whereas
middle LAD was higher than distal LAD (p = 0.01) and
proximal was also greater than distal (p = 0.04).
Immunohistochemistry
On light microscopy of the LAD middle segment sec-
tions, a thinner layer of cEAT covered the adventitia
than the adjacent two segments, suggesting no regrowth
of remnant fat 3 months after adipectomy. Figure 4A
shows representative photomicrographs of the pre-
sence, distribution and intensity of immunostaining of
T-cadherin, SRA and adiponectin in the three segments
of the LAD. T-Cadherin was strongly positive in the
endothelial layer, but also present in the sub-endothelial
neointima in proximal and distal LAD, but to a lesser
extent in the middle vessel wall. SRA was present in the
endothelial layer and neointima. Adiponectin was
present in the endothelial layer and very dispersed over
the media. As shown in Figure 4B (panel A), when these
markers in all samples were quantitated, there was a
significant reduction in mean percentage area of
T-cadherin staining in the intima-media from 4.77 ±
0.92% in the proximal and 4.71 ± 0.66% in the distal
LAD segments to 2.67 ± 0.66% in the middle LAD (pro-
ximal to middle LAD p = 0.047 and distal to middle
LAD p = 0.01 using 2-tailed t tests). SRA staining(Figure 4B, panel B) was 0.73 ± 0.25% in the proximal
LAD and 0.26 ± 0.08% in the middle LAD which was
significantly different (p = 0.035) by a 1-tail t test with a
trend towards significance (p = 0.07 in a 2-tailed t test),
and 0.74 ± 0.45% in the distal LAD which although
higher than the middle LAD was not significantly diffe-
rent. Adiponectin staining (Figure 4B, panel C) was
significantly lower in the middle LAD 3.28 ± 1.04%
versus the proximal 8.94 ± 2.32% (p = 0.04 in a 1-tailed t test
versus a trend for significance p = 0.08 in a 2-tailed t test).
In the distal LAD, adiponectin measured 5.12 ± 1.57%
which was not different to either the proximal or middle
Figure 3 IVUS images and analysis. A-C: IVUS images, distance between white dots =1.0 mm. A. Normal vessel with no intimal thickening; a.
guidewire artifact b. IVUS catheter c. clear lumen d. lumen of parallel vessel. B. Analysis example; a. atheroma covering 3 segments of a 16
segment designation ~ 19%. C. a. Concentric neointimal ring of atheroma. D. Circumferential plaque length in each 15 mm of proximal, middle
and distal left anterior descending coronary artery (LAD) at the time of adipectomy (survival, lower line) and at sacrifice (3 months later, upper
line). Values are mean ± sem for 7 pigs. Asterisk indicates p < 0.05 between upper and lower proximal and distal LAD portions.
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cent staining for tryptase, CD3, TNFα, MCP-1 and resis-
tin between the proximal, middle and distal LAD.
CT quantification of epicardial fat
In Figure 5, CT scans done on 6 of the 8 surviving swine
showed an increase in total EAT volume from 9.7 ±
1.1 cm3 at adipectomy to 13.5 ± 0.7 cm3 at time of
sacrifice, representing a 39% increase (p = 0.006) over
3 months. Due to inadequate numbers of data points,
CT data could not be correlated with the IVUS data to
determine if a relationship existed between changes in
EAT volume and total plaque burden.
Gene expression
Table 1 shows the expression in cEAT and paracardial
fat of genes linked to atherogenesis, namely those in-
volved in inflammation, reactive oxygen species and
redox reactions, angiogenesis and endothelial cell func-
tion. The data in each fat depot are expressed as the
ratio of experimental to control pig fat depots. In
EAT, there were significant and substantial fold
increases in mRNA expression of pro-inflammatory
11β-hydroxysteroid dehydrogenase (11βHSD-1), CCL19,
CCL21 and PGD2S; anti-inflammatory adiponectin; pro-
oxidant gp91phox [NADPH oxidase], angiogenic VEGF
and VEGFGR1 and vascoconstrictive angiotensinogen.There were no changes in pro-inflammatory toll-like re-
ceptor 4 [TLR4], CCR7, TNFα, IL-1β, IL-6, IL-8, leptin,
Unc5b, netrin-1 and NGF; redox genes eNOS, superoxide
dismutase [SOD], cyclooxygenase 2 and cytochrome oxi-
dase; and vasoconstrictor endothelin-1 and vasodilator ad-
enosine receptor 1. By contrast, in paracardial fat relative
to cEAT, 11βHSD-1 and CCL21 were normal; CCL19,
PGD2S, adiponectin pro-oxidant gp91phox [NADPH oxi-
dase] VEGF, VEGFGR1 and angiotensinogen were up-
regulated to much lesser degrees; and the remaining genes
were similar except for TLR4 and endothelin-1 which
were modestly (~2 fold) increased.
Discussion
We present experimental evidence that, in Ossabaw
miniature swine, selective surgical excision of adipose
tissue in direct contiguity with one of the epicardial co-
ronary arteries attenuated the progression of atheroscle-
rosis, thus supporting the hypothesis that cEAT could
contribute to underlying coronary atherogenesis [13].
The findings are applicable to the early stages of CAD
because of the relatively young age of the animals, the
short duration of atherogenic diet feeding, and the lack
of observed flow-limiting coronary stenosis typical of ad-
vanced clinical disease. We acknowledge the substan-
tially high LDL cholesterol levels (>500 m/dL) in the
obese group. We have conducted other studies in which
Figure 4 Immunohistochemistry of proximal, middle, and distal LAD. A: Representative photomicrographs of brown immunostaining for
T-Cadherin [A, upper panels], SRA [B, middle panels] and Adiponectin [C, lower panels] in the designated LAD segments. Arrows point to brown
positive stains in the endothelial and sub-endothelial neo-intima for each marker. Scale bar = 500 microns. B: Percent immunohistochemical
staining of the proximal, middle and distal 15 mm segments of left anterior descending coronary wall intima-media for a; T-Cadherin, b; SRA and
c; adiponectin. The same letters (a-a, b-b) indicate that the mean ± sem in the segments are significantly different (n = 8 separate samples from
each segment, p < 0.05).
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ation, which yielded substantial coronary atherosclerosis.
We predict a similar result of adipectomy. This very high
LDL cholesterol level for a short duration is similar to
LDLR−/− humans, who have substantial atherosclerosis.
Horton and colleagues refer to this phenomenon as the ef-
fect of cumulative LDL cholesterol in g/dL-years [20].
We showed that in the middle LAD at the adipectomy
site, progression of CAD was not significant compared
to the significant increases in circumferential plaque in
the adjacent, unperturbed proximal and distal segments.
Thus, in the middle LAD segment, the increase in mean
plaque length was 1.4-fold compared to 1.9- and 2.9-fold
in the proximal and distal LAD, respectively. There were
higher mean values and greater variability in baseline
plaque length in the middle compared to the proximal
and distal segments at the time of adipectomy, sugges-
ting that the attenuated progression of atheroma couldhave been the consequence of higher initial plaque
thickness at the inception of the protocol. However, a
two-tailed, paired t-test did not indicate that this base-
line difference was statistically significant (p = 0.26). The
reason for the variability in the middle LAD plaque di-
mensions is not clear, since prior studies have indicated
that mean plaque burden is greatest proximally and
decreases distally in the LAD [12]. One possibility is that
adipectomy could have perturbed underlying plaque struc-
ture or vasomotor responses and interfered with IVUS
measurements performed under heparin immediately after
adipectomy. However, we have recently shown that cEAT
has uniformly adverse effects on coronary artery function
[21], in contrast to protective effect of PVAT in the aorta
and other arteries. This explains why we observed no
adverse mechanical changes after adipectomy.
We resected fat from one coronary artery for several
reasons. Resection of as much fat as possible off the
Figure 5 Epicardial adipose tissue volumes of swine on high-fat
diet before adipectomy and 3 months after the procedure.
Letter a indicates significant difference, p < 0.01.
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cEAT on the LAD was the most accessible site within
the operative field of exposure compared to either the
circumflex or right coronary arteries, which would lessen
both intraoperative trauma, morbidity and mortality,
and the risk of post-operative complications. This stra-
tegy targeting one rather than two vessels was subse-
quently vindicated by the low intraoperative mortality
(1 of 9 pigs) and no noticed post-operative complica-
tions. Finally, the longitudinal time course of the experi-
ment enabled the pigs to act as their own controls.
Immunoreactivity for T-cadherin was predominantly
localized to the endothelium as previously established
[22], but also to the neo-intima. It is considered to be a
marker of active atherosclerosis [22] and a major recep-
tor for adiponectin in the vasculature [23]. T-cadherin
and SRA, the scavenger receptor for LDL-cholesterol on
plasma membranes of plaque macrophages and foam
cells [24,25], were reduced in the middle LAD intima-
media implying less atherogenesis. Paradoxically, anti-
inflammatory immunoreactive adiponectin in the same
LAD segment was reduced significantly by 68%, despite
a ~7-fold upregulation of adiponectin mRNA expression
in overlying cEAT; thus, one might surmise that adipo-
nectin released by epicardial adipocytes might not have
been able to penetrate the coronary wall if such a mech-
anism exists. While a majority of the literature describes
a decrease in adiponectin expression in CAD patients,
we speculate that the 6.7-fold increase in obese pig
cEAT mRNA was a compensatory response and that
there must be some block in mRNA translation. We
have previously reported that serum adiponectin isdecreased in obese versus lean Ossabaw swine [26]. On
the other hand, there were no changes in vessel wall
CD3 (a T lymphocyte cell marker), tryptase (a basophil
marker), TNFα, MCP-1, and resistin.
The mechanisms whereby selective adipectomy might
have attenuated the progression of CAD remain to be
established, but hypothetically include (i) the removal of
factors generated by cEAT that could contribute to
atherogenesis by direct diffusion through the porous ad-
ventitia into the coronary intima-media [19], such as re-
active oxygen species (ROS) and pro-inflammatory
cytokines and/or (ii) the disruption of vasa vasorum in
the adventitia and in the closely adjacent cEAT [27],
which might interfere with vasocrine signaling of athero-
genic adipokines [19] and restrict mononuclear cell
access into the intima-media. The evidence for these
suppositions includes the fact that relative to control
cEAT, there was significant up-regulation in atheroscler-
otic cEAT of pro-inflammatory 11βHSD-1, CCL19,
CCL21 and PGD2S; gp91phox [NADPH oxidase], a
major source of vascular ROS; VEGF and VEGFGR1,
which partake in vasa vasorum neogenesis and angioten-
sinogen, which promotes endothelial dysfunction and
vasoconstriction. Similar to our current findings in pigs,
we reported 3-fold up-regulation of 11βHSD-1 gene ex-
pression in human EAT adjacent to severe CAD over
controls without CAD [8]. Pharmacological inhibition
of 11βHSD-1 prevented aortic plaque progression in
a murine model of atherosclerosis, suggesting that
11βHSD-1 may play a role in atherogenesis [28]. Lymph-
oid chemokines CCL19 and CCL21 are crucial for the
recruitment of circulating naive T cells into lymph
nodes. Increased levels of CCL19 and CCL21 have been
reported within the atherosclerotic lesions of ApoE−/−
mice, in human atherosclerotic carotid plaques, and in
plasma of CAD patients [28]. In mice, PGD2S deficiency
induces obesity and facilitates aortic atherosclerosis [29],
suggesting it is normally protective and anti-atherogenic
in this species. The role of PGD2S in porcine athero-
sclerosis has not been reported, but -regulation of
PGD2S in EAT in our study was associated with ameli-
oration of atherosclerosis, suggesting the possibility that
this pro-inflammatory prostanoid might otherwise be
harmful either alone or in conjunction with other adipo-
kines. No changes were observed in cEAT in the expres-
sion of TLR4 and acute phase cytokines TNFα, IL-1β,
IL-6, IL-8 as well as the anti-oxidant genes eNOS and
SOD. Finally, the enhanced expression of a selected
array of pro-atherosclerotic genes in cEAT over paracar-
dial fat attests to the relative specificity of the genomic
response of cEAT associated with CAD that has been
similarly documented in humans with CAD [8].
Epicardial fat volume determined by sequential CT scans
significantly increased over 3 months of hypercaloric
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sult in major expansion of visceral retroperitoneal and in-
traperitoneal as well as subcutaneous abdominal fat
depots in the same animal model [30]. Although our ex-
perimental design using pigs as their own controls in a
longitudinal study has its strengths, there are also limita-
tions in the lack of sham-adipectomies in age- and
gender-matched pigs fed hypercaloric atherogenic diet.
Future studies should employ sham-operated animals;
randomization of experimental and control pigs; blinding
of both the ultrasonographer and two independent IVUS
data analysts to the pig group designation; reversing
heparin anti-coagulation during IVUS with protamine
sulphate so that IVUS can be done before surgery; CT
scanning using radio-contrast dye to delineate the coron-
aries and to quantitate cEAT area around coronary
plaques per se rather than EAT covering the entire myo-
cardium; and immunohistochemical and mRNA analysis
of cEAT and the coronary wall for expression of genes and
proteins known to be important mediators of or partici-
pants in atherogenesis. To make these studies more trans-
latable to clinical treatment, more clinical outcomes
studies in the swine model would be helpful, for example,
monitoring hard clinical endpoints such as MI, fatal
events, etc. over a longer duration.
Our translational research project was done using ex-
perimental conditions prohibited in man by obvious
ethical constraints and, with the provisos noted above,
supports the human epidemiological evidence for a direct
relationship between EAT and CAD. At this juncture and
until more rigorous evidence is available one way or the
other, it is premature to advocate an adipectomy as surgi-
cal treatment to attenuate the progression of CAD. Ra-
ther, it would be more appropriate from a clinical point
of view if non-invasive methods were devised to shrink
epicardial fat volume to serve the same beneficial pur-
pose. In this regard, weight loss by caloric restriction
and/or exercise in obese human subjects is associated
with shrinkage of EAT volume by 9-32% of baseline in
different reports [13,31], but it is not known whether this
is accompanied by decreases in chronic inflammation
in EAT or reduction in CAD burden [12].
Conclusions
The results of our pilot study are consistent with the hy-
pothesis that selective coronary artery adipectomy atten-
uates the progression of early atherosclerosis, setting the
stage for performing definitive future studies using sham
operation controls. These studies will determine whether
coronary adipectomy attenuates stable atherosclerotic
plaques typically found in clinically advanced disease.
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